GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Profit Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Profit Margin (%) | 24.12 | 17.43 | 20.71 | 12.49 | 11.71 |
What is the latest Cash Profit Margin ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash Profit Margin |
|---|---|
| Mar2025 | 24.12 |
| Mar2024 | 17.43 |
| Mar2023 | 20.71 |
| Mar2022 | 12.49 |
| Mar2021 | 11.71 |
How is Cash Profit Margin of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash Profit Margin | % Change | |
|---|---|---|---|
| Mar2025 | 24.12 | 38.38 | |
| Mar2024 | 17.43 | -15.84 | |
| Mar2023 | 20.71 | 65.81 | |
| Mar2022 | 12.49 | 6.66 | |
| Mar2021 | 11.71 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Profit Margin ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹38,620.7 Cr | -6.3% | -11.3% | -14.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -6.3% |
-11.3% |
-14.7% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses